Perrigo Company plc Current Assets
Perrigo Company plc (PRGO) had Current Assets of $2.45 billion as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-05
- 2026-06-27: Assets, Current $2.45B.
- 2026-03-28: Assets, Current $2.71B.
- 2025-12-31: Assets, Current $2.80B.
- 2025-09-27: Assets, Current $2.88B.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-27 | $2.45B 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $2.71B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $2.80B 10-Q · filed 2026-08-05 | |
| 2025-09-27 | $2.88B 10-Q · filed 2025-11-05 | |
| 2025-06-28 | $2.62B 10-Q · filed 2025-08-06 | |
| 2025-03-29 | $2.53B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $2.48B 10-K · filed 2026-02-26 | |
| 2024-09-28 | $3.71B 10-Q · filed 2024-11-06 | |
| 2024-06-29 | $2.96B 10-Q · filed 2024-08-02 | |
| 2024-03-30 | $2.81B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $2.83B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $2.77B 10-Q · filed 2023-11-07 | |
| 2023-07-01 | $2.77B 10-Q · filed 2023-08-08 | |
| 2023-04-01 | $2.74B 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $2.72B 10-K · filed 2024-02-27 | |
| 2022-10-01 | $2.58B 10-Q · filed 2022-11-08 | |
| 2022-07-02 | $2.65B 10-Q · filed 2022-08-09 | |
| 2022-04-02 | $3.94B 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $3.86B 10-K · filed 2023-02-28 | |
| 2021-10-02 | $4.23B 10-Q · filed 2021-11-12 | |
| 2021-07-03 | $4.42B 10-Q · filed 2021-08-11 | |
| 2021-04-03 | $4.49B 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $3.13B 10-K · filed 2022-03-01 | |
| 2020-09-26 | $3.40B 10-Q · filed 2020-11-05 | |
| 2020-06-27 | $3.80B 10-Q · filed 2020-08-05 | |
| 2020-03-28 | $3.05B 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $2.73B 10-K · filed 2021-03-01 | $2.76B 10-K · filed 2020-02-27 |
| 2019-09-28 | $2.74B 10-Q · filed 2019-11-06 | |
| 2019-06-29 | $3.44B 10-Q · filed 2019-08-08 | |
| 2019-03-30 | $3.01B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.90B 10-K · filed 2020-02-27 | |
| 2018-09-29 | $2.77B 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.78B 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.90B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $2.82B 10-K · filed 2019-02-27 | |
| 2017-09-30 | $2.97B 10-Q · filed 2017-11-09 | |
| 2017-07-01 | $2.82B 10-Q · filed 2017-08-10 | |
| 2017-04-01 | $5.11B 10-Q · filed 2017-05-30 | |
| 2016-12-31 | $2.81B 10-K · filed 2018-03-01 | |
| 2016-10-01 | $2.62B 10-Q/A · filed 2017-05-23 | $2.63B 10-Q · filed 2016-11-10 |
| 2016-07-02 | $3.03B 10-Q/A · filed 2017-05-22 | $3.03B 10-Q · filed 2016-08-10 |
| 2016-04-02 | $3.01B 10-Q/A · filed 2017-05-22 | $2.97B 10-Q · filed 2016-05-16 |
| 2015-12-31 | $2.79B 10-K · filed 2018-03-01 | $2.74B 10-KT · filed 2016-02-25 |
| 2015-09-26 | $2.88B 10-Q · filed 2015-11-02 | |
| 2015-06-27 | $3.23B 10-K · filed 2017-05-22 | $3.18B 10-K · filed 2015-08-13 |
| 2015-03-28 | $5.13B 10-Q · filed 2015-04-29 | |
| 2014-12-27 | $5.36B 10-Q · filed 2015-02-05 | |
| 2014-09-27 | $2.63B 8-K · filed 2014-11-20 | |
| 2014-06-28 | $2.55B 10-K · filed 2017-05-22 | $2.55B 10-K · filed 2014-08-14 |
| 2014-03-29 | $2.30B 10-Q · filed 2014-05-07 | |
| 2013-12-28 | $2.29B 10-Q · filed 2014-02-06 | |
| 2013-09-28 | $4.73M 10-Q · filed 2013-11-04 | |
| 2013-06-29 | $2.24B 10-K · filed 2014-08-14 | $131.00 10-Q · filed 2013-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |